Table Of Content

Subject index of Volume 129 - 1997 \bstinence 56 DFP 183 Midazolam 339 ABT-418 225 Dihydro-B-erythroidine 390 Monoamine turnover 225 Abuse liability testing 329 5,7-Dihydroxytryptamine 48 Mood 66 Acetylcholine 85 Discrimination 289 Morphine 56 Acetylcholinesterase 183 Discriminative avoidance behavior 322 Motor coordination Acquisition 206 Dizocilpine (MK-801) 153 Mouse brain 225 Acute dependence 56 DMPP 225 Mu receptors 233 Acute tolerance 249 Dopamine 112, 121, 141, 161, 168,249,271, Muscarinic 299, 311 Adenosine antagonist 299, 311 Muscimol 339 Adinazolam 265 Dosage 23 Nalbuphine 233 Aggression 197 Dose 206 Naloxone 56, 99, 289 \ging 91 Drug abuse 96 Naltrexone 15, 99 \gonist-antagonist 32 Drug discrimination 257, NDMAD 265 Alcohol 15, 128 Drug metabolism 265 Neostriatum 112 Alcohol addiction 99 DTG 215 Neuroleptic 141, 168 Alcohol reinforcement 99 EEG 192, 382 Neuroleptic medication Alcohol self-administration 72, EEG slowing 285 Neuropeptide 243 Alfentanil 233 Efficacy 233 (—)-Nicotine 96 Alzheimer disease 285 lectrophysiology 215 Nicotine 35, 192, 249, 257 Amphetamine 112, 141, 153, I levated plus-maze 365 Nicotine dependence 348 7 I motion 382 Nicotine withdrawal 348 (+)-Anabasine I ndogenous opioid peptides 99 NIH 10443 233 Animal model 72, | Ethanol 72, 135 V-Methyl-p-Aspartate (NMDA) 215 Antidepressants Ethnicity 265 V-methyl-b-aspartate receptors 96 Antiepileptic drugs 3 Family history of alcoholism 15 NNC 19-1228 168 \ntinociception 233 Food intake 179 NNC 22-0031 168 Anxiety 141, 197, 365 Food restriction 16] Nonhuman primates | \polipoprotein E 285 GABA 27, 372 Norepinephrine 299, 31] \ppainr vievo nafftini ty 233 GABA (gamma-aminobutyric acid) 339 NPA 153 Arousal 382 Ganglioside 322 Nucleus accumbens 112 Attention 1.24, 382 Genetic models 99 Olanzapine 79 \utomatic processing 2 Genetics 15 Olfaction 183 Autoshaping 206 Glutamate 96 Olfactory learning 8&5 Baclofen 339 Glycine 96 Ontogeny 12] BD-737 215 GMI 322 Operant behavior Behavioral economics 72 Hippocampus 183, 215 Operant behaviour 48, 390 Behavioral models 168 5S-HT,, receptors 365 Operant responding 233 Benzodiazepine 2 5-HT, receptors 79 Opiates 56 Bicuculline 27, 339 Human studies 357 Opioid addiction 99 Biphasic Alcohol Effects Scale 15 Hydromorphone 329 Opioid antagonists 99 Bipolar disorder 5-Hydroxytryptamine 48 Opioid dependence 329 Body weight 23, It Ibogaine 249 Opioid receptors 99, 233 Buprenorphine f In vivo 249 Opioids 289 Caffeine | Inhibitory avoidance 161 Organophosphate 183 Cardiovascular system | Interaction 128 Panic disorder 243, 35 CK, receptor antagonist 243 Interval bisection procedure 48 (+)-Pentazocine 215 GP 35348 27 Intravenous self-administration 35 Pentobarbital 339 hlorisondamine 348 IV intake 206 Phencyclidine 79, 96, 339 hoice 72 JO-1784 215 Phosphodiesterase inhibition holecystokinin 243, 357 L-687.384 215 Plasma growth hormone 179 hronic nimodipine 91 Latent inhibition Platelet 44 1-988 243 Lever press 72 p-MPPI 365 locinnamox 233 Lithium 23, 44 Predisposition ocaethylene 128 (—)-Lobeline 7 225 Pre-exposure 2 ocaine 121, 128, 206, 299, 311 Locomotion 183 Prevention of relapse 99 onditioned reinforcement 14] Locomotor activity ei oe Procedural learning 271] onditioned stimulus 14{] Locomotor behavior 121 Progabide 7 onditioned taste aversion 2 Lordosis 372 Protein phosphorylation 44 ‘onvulsions 299 Maternal behavior 85 Psychotropic 265 ortical EEG 91 Mecamylamine 257, 348 Punishment 141 )-Cytisine 225 Memory 66, 322 Quinine Cytisine 25 Memory for duration 48 Quinpirole 121 Cytochrome P450 265 Mesolimbic dopamine reward system 99 Rat 35, 48, 141, 168, 249 D, and D, receptors — If Metrifonate 91 Rats 72, 128, 135, 206, 3 39 Dependence 56 Mice 322, 365 Reaction time 135 Depression 197 Microdialysis 192, 249 Reaction times 66 Vi Receptivity 3 Serum levels Sumatriptan R>e ceptor reserve Sex 23 Taste 289 Reinforcement Sexual behavior letramethylammonium 348 REM sleep 295 Sexual motivation THA 225, 285 Respiration Sheep 85 Thiamine 66 Response to novelty Sigma 299 311 THIP 339 R unt 16 SKF-38393 121 Time discrimination 48 Rodents 19 Smoking 382 Variable-interval schedule idminist ation ) Social drinkers Venlafaxine 295 Schedule-controlled respondin Spare receptors Vigilance 135, 382 sch zophret Spatial learning VitaminB I 66 Strain differences Volume of distribution Stress 382 Withdrawal 56 Striatal dopamine Women 179 Substitutability Xanthines | Sucrose 72, 289 Young verus aged ir rat 91 ie 3 ips ane Roptes